Surgical bailout after transcatheter aortic valve replacement: Hospital procedural volume matters!

2022 ◽  
Vol 99 (1) ◽  
pp. 169-170
Author(s):  
Yoshiyuki Okuya ◽  
Issam D. Moussa
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Procedural Volume

scholarly journals Procedural Volume and Outcomes for Transcatheter Aortic-Valve Replacement

2019 ◽  
Vol 380 (26) ◽  
pp. 2541-2550 ◽  
Author(s):  
Sreekanth Vemulapalli ◽  
John D. Carroll ◽  
Michael J. Mack ◽  
Zhuokai Li ◽  
David Dai ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Procedural Volume

scholarly journals Impact of Hospital Procedural Volume on Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve

2020 ◽  
Vol 13 (15) ◽  
pp. 1841-1843
Author(s):  
Nicholas Kassis ◽  
Anas M. Saad ◽  
Essa Hariri ◽  
Mohamed M. Gad ◽  
Omar M. Abdelfattah ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Bicuspid Aortic Valve ◽  
Transcatheter Aortic Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Procedural Volume

scholarly journals National Analysis of Short-Term Outcomes and Volume-Outcome Relationships for Transcatheter Aortic Valve Replacement in the Era of Commercialization

Cardiology ◽  
2015 ◽  
Vol 133 (1) ◽  
pp. 58-68 ◽  
Author(s):  
Andreas R. de Biasi ◽  
Subroto Paul ◽  
Abu Nasar ◽  
Leonard N. Girardi ◽  
Arash Salemi
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Inhospital Mortality ◽  
Short Term ◽  
Transcatheter Aortic Valve ◽  
Procedural Volume ◽  
Volume Outcome ◽  
National Analysis

Objectives: We queried the 2012 National Inpatient Sample in order to (1) further describe the short-term outcomes for transcatheter aortic valve replacement (TAVR) and (2) characterize possible volume-outcome relationships and other prognostic factors for this procedure. Methods: Demographics and inhospital outcomes were tabulated for all patients, as were hospital characteristics and procedural-volume data for all centers at which patients underwent TAVR. Logistic regression analyses were performed to identify independent risk factors for mortality or morbidity. Results: 7,635 patients aged ≥18 years received TAVR during the study period; 84.5% (n = 6,450) underwent transfemoral TAVR and the rest were treated transapically. The median age was 83 years (IQR 77-88 years) and cardiovascular comorbidities were widespread. Overall inhospital mortality was 5.0% (n = 380), and 1.4% (n = 105) of the patients experienced a stroke. All-cause procedure-related morbidity was 24.7% (n = 1,885). Annual hospital TAVR volume did not predict inhospital mortality or morbidity (OR 1.00, 95% CI 0.99-1.00, p = 0.111 and OR 1.00, 95% CI 0.99-1.00, p = 0.947, respectively). Conclusions: Our analysis helps to confirm the short-term safety profile of TAVR and further demonstrates that inhospital outcomes have remained acceptable as this procedure has become commercialized.

Sign in / Sign up

Export Citation Format

Share Document